US Stock MarketDetailed Quotes

Compass Therapeutics (CMPX)

Watchlist
  • 1.980
  • +0.110+5.88%
Trading May 13 14:25 ET
356.57MMarket Cap-4.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics (CMPX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
850K
0
0
850K
Operating revenue
--0
--0
--0
--0
--0
--0
--850K
--0
--0
--850K
Cost of revenue
Gross profit
Operating expense
12.99%20.3M
26.73%72.84M
8.54%17.99M
29.23%15.82M
32.53%21.07M
40.69%17.97M
14.12%57.48M
7.67%16.57M
2.62%12.24M
19.18%15.9M
Selling and administrative expenses
40.66%6.91M
11.48%16.87M
22.12%4.32M
-17.54%2.99M
-1.48%4.65M
51.23%4.91M
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
-General and administrative expense
40.66%6.91M
11.48%16.87M
22.12%4.32M
-17.54%2.99M
-1.48%4.65M
51.23%4.91M
23.61%15.13M
19.18%3.54M
17.19%3.63M
51.61%4.72M
Research and development costs
2.57%13.39M
32.18%55.97M
4.86%13.67M
48.93%12.83M
46.90%16.42M
37.09%13.05M
11.08%42.34M
4.93%13.04M
-2.48%8.61M
9.30%11.17M
Operating profit
-12.99%-20.3M
-28.63%-72.84M
-8.54%-17.99M
-29.23%-15.82M
-40.02%-21.07M
-40.69%-17.97M
-12.43%-56.63M
-7.67%-16.57M
-2.62%-12.24M
-12.81%-15.05M
Net non-operating interest income expense
-12.33%6.4M
46.07%2.32M
-11.38%1.56M
-39.06%1.2M
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
Non-operating interest income
----
-12.33%6.4M
46.07%2.32M
-11.38%1.56M
-39.06%1.2M
----
-7.59%7.3M
-20.81%1.59M
-10.40%1.76M
-4.37%1.97M
Other net income (expense)
48.69%1.98M
0.00%-50K
-15K
-32.78%1.33M
-61.29%-50K
Special income (charges)
----
----
----
----
----
----
----
----
----
--0
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
----
----
----
--0
Other non- operating income (expenses)
48.69%1.98M
0.00%-50K
----
----
---15K
-32.78%1.33M
-61.29%-50K
----
----
----
Income before tax
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
Income tax
0
0
0
Net income
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
Net income continuous Operations
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
Minority interest income
Net income attributable to the parent company
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.05%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.19%-10.48M
-15.94%-13.08M
Basic earnings per share
16.67%-0.1
-16.67%-0.42
18.18%-0.09
0.00%-0.08
-40.00%-0.14
-50.00%-0.12
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
Diluted earnings per share
16.67%-0.1
-16.67%-0.42
18.18%-0.09
0.00%-0.08
-40.00%-0.14
-50.00%-0.12
-9.09%-0.36
-10.00%-0.11
0.00%-0.08
-11.11%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 000000850K00850K
Operating revenue --0--0--0--0--0--0--850K--0--0--850K
Cost of revenue
Gross profit
Operating expense 12.99%20.3M26.73%72.84M8.54%17.99M29.23%15.82M32.53%21.07M40.69%17.97M14.12%57.48M7.67%16.57M2.62%12.24M19.18%15.9M
Selling and administrative expenses 40.66%6.91M11.48%16.87M22.12%4.32M-17.54%2.99M-1.48%4.65M51.23%4.91M23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M
-General and administrative expense 40.66%6.91M11.48%16.87M22.12%4.32M-17.54%2.99M-1.48%4.65M51.23%4.91M23.61%15.13M19.18%3.54M17.19%3.63M51.61%4.72M
Research and development costs 2.57%13.39M32.18%55.97M4.86%13.67M48.93%12.83M46.90%16.42M37.09%13.05M11.08%42.34M4.93%13.04M-2.48%8.61M9.30%11.17M
Operating profit -12.99%-20.3M-28.63%-72.84M-8.54%-17.99M-29.23%-15.82M-40.02%-21.07M-40.69%-17.97M-12.43%-56.63M-7.67%-16.57M-2.62%-12.24M-12.81%-15.05M
Net non-operating interest income expense -12.33%6.4M46.07%2.32M-11.38%1.56M-39.06%1.2M-7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M
Non-operating interest income -----12.33%6.4M46.07%2.32M-11.38%1.56M-39.06%1.2M-----7.59%7.3M-20.81%1.59M-10.40%1.76M-4.37%1.97M
Other net income (expense) 48.69%1.98M0.00%-50K-15K-32.78%1.33M-61.29%-50K
Special income (charges) --------------------------------------0
-Gain on sale of property,plant,equipment --------------------------------------0
Other non- operating income (expenses) 48.69%1.98M0.00%-50K-----------15K-32.78%1.33M-61.29%-50K------------
Income before tax -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M
Income tax 000
Net income -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M
Net income continuous Operations -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M
Minority interest income
Net income attributable to the parent company -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.05%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.19%-10.48M-15.94%-13.08M
Basic earnings per share 16.67%-0.1-16.67%-0.4218.18%-0.090.00%-0.08-40.00%-0.14-50.00%-0.12-9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1
Diluted earnings per share 16.67%-0.1-16.67%-0.4218.18%-0.090.00%-0.08-40.00%-0.14-50.00%-0.12-9.09%-0.36-10.00%-0.110.00%-0.08-11.11%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.74%
Sample Name
Sample Code
 +18.08%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.88%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.75%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.56%
Sample Name
Sample Code
 +10.80%
Sample Name
Sample Code
 +9.49%
4
Kingsoft Cloud
KC
+8.48%
5
Hesai
HSAI
+7.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -